Cosmo pharmaceuticals


Patents and other intellectual property rights are important to our business. Cosmo has been pursuing a double-cover selective country patent strategy. 

Our intellectual property rights have material value, and we have to act to protect them. A global MMX® patent protecting the platform technology has been filed and granted in practically all major countries and deriving product patents have been filed and received in most of the countries. In selective cases, the Company subsequently, files process and use patents.

In accordance with 35 USC § 287(a), Cosmo provides United States Patent information concerning its products on this website. Cosmo has also provided information on this website concerning European patents that cover certain products. Each listed product is patented under, made under, or used under one or more of the patents listed with the associated product name. 

The patent information displayed on this website is believed to be accurate as of the most recent update of the page but should not be considered exhaustive. The omission of a patent from a product’s entry on this website is not a representation or admission by Cosmo that the patent does not cover the product, nor does the absence of any listing on this website for a specific product constitute a representation or admission by Cosmo that the product is unpatented.

Cosmo has attempted to keep the information on this website reasonably current, but certain patents listed on this website may have expired since the page was last updated.

Download the patent list or read current Financial Report